En
Register Log in
  1. Main
  2. Conference
  3. Fundamental and applied research for key propriety...
  4. FISH technologies in the field of clinical and bas...

FISH technologies in the field of clinical and basic research (literature review)

Proceeding
DOI: 10.31483/r-139064
Open Access
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Creative commons logo
Published in:
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Authors:
Daria V. Iakovleva 1 , Aidar R. Zimnurov 1 , Iuliia A. Anashkina 2 , Natalia V. Firsova 1 , Konstantin N. Firsov 2 , Elena I. Antonova 1
Work direction:
Молекулярная биология, генетика, микробиология
Pages:
56-68
Received: 30 May 2025

Rating:
Article accesses:
114
Published in:
Информрегистр РИНЦ
1 Nauchno-issledovatel'skii tsentr fundamental'nykh i prikladnykh problem bioekologii i biotekhnologii FGBOU VO "Ul'ianovskii gosudarstvennyi pedagogicheskii universitet im. I.N. Ul'ianova"
2 Ulyanovsk State Pedagogical University named after I. N. Ulyanov
For citation:
Iakovleva D. V., Zimnurov A. R., Anashkina I. A., Firsova N. V., Firsov K. N., & Antonova E. I. (2025). FISH technologies in the field of clinical and basic research (literature review). Fundamental and applied research for key propriety areas of bioecology and biotechnology, 56-68. Чебоксары: PH "Sreda". https://doi.org/10.31483/r-139064

Abstract

Статье рассматриваются методы технологии FISH (флуоресцентной in situ гибридизации), их модификации, применение в клинической диагностике и фундаментальных исследованиях.

References

  1. 1. Нугиc В.Ю. FISH-метод: способ цитогенетической ретроспективной оценки дозы (обзор) / В.Ю. Нугис // Саратовский научно-медицинский журнал. – 2016. – №12 (4). – С. 671–678. EDN YPYFKV
  2. 2. Bishop R. Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance // Bioscience Horizons: The International Journal of Student Research. 2010. Vol. 3. №1. Pp. 85–95.
  3. 3. Boyd C., Boyle D. Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future // Cytopathology. 2012. №23 (5). – Pp. 286–294.
  4. 4. Carter D. How fluorescence in situ hybridization (FISH) fits into cancer care The University of Texas MD Anderson Cancer Center // The University of Texas MD Anderson Cancer Center. 2021.
  5. 5. Casaluce F., Sgambato A., Maione P. [et al.]. C. ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC // Target Oncol. 2013. №8 (1). Pp. 55–67. DOI 10.1007/s11523-012-0250-9. EDN UMBEYJ
  6. 6. Casper R.M., Leonard K., Mpho M., Bono N. Recent Molecular Techniques in Cytogenetics. 2025.
  7. 7. Chen J., Shi Q., Zhang J. [et al.]. Detection of mosaic chromosome 21 aneuploidy in vivo with CB-FISH method // Chinese journal of medical genetics. 2000. Vol. 17 (3). Pp. 196–199.
  8. 8. Chudova I. Fluorescence in situ hybridization. In: Chromosomal alterations: methods, results and importance in human’s health. Berlin, Heidelberg, New York: Springer-Verlag. 2007. Pp. 285–299.
  9. 9. Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies // Vienna: IAEA. 2011. P. 229.
  10. 10. de Barros A.V., Sczepanski Th.S., Cabrero J., Artoni R.F. Fiber FISH reveals different patterns of highresolution physical mapping for repetitive DNA in fish. // Aquaculture. 2018. Vol. 322. Pp. 47–50.
  11. 11. Dhabe A., Islam R., Ramakrishnan K., Parihar M. Role of Cytogenetics and FISH in laboratory workup of B cell precursor acute lymphoblastic leukemia // Indian J Med Paediatr Oncol. 2023. №44 (05). Pp. 482–493. DOI 10.1055/s-0043-1766133. EDN VXODKF
  12. 12. Dietel M., Johrens K., Laffert M. [et al.]. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance // Cancer Gene Ther. 2013. №20 (4). Pp. 211–221.
  13. 13. Eckel H., Kleinstein J., Wieacker P., Stumm M. Multi-locus (ML)-FISH is a reliable tool for nondisjunction studies in human oocytes // Cytogenet. Genome. 2003. №103. Pp. 47–53.
  14. 14. Gandhi L., Janne P. Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target // Clin Cancer Res. 2012. Vol. 18 (14). Pp. 3737–3742.
  15. 15. Hu L., Ru K., Zhang L. [et al.]. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine // Biomarker Research. 2014. Vol. 2. DOI 10.1186/2050-7771-2-3. EDN EEHUMZ
  16. 16. Jiang H., Xue Y., Wang Q. [et al.]. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure // Leuk Res. 2012. №36 (4). Pp. 448–452.
  17. 17. Khalaf S.D., Alhamadany A.Y., Kader M.A. Fluorescence in situ hybridization (FISH): types and application: a review // NTU Journal of Pure Sceinces. 2023. №2 (2). Pp. 37–53.
  18. 18. Kim H., Lim S., Kim H. [et al.]. The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma // Ann Oncol. 2013. №24 (9). Pp. 2364–2370.
  19. 19. Landau D., Wu C. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics // Genome Med. 2013. №5 (5):47.
  20. 20. Pathmanathan N., Bilous A. HER2 testing in breast cancer: an overview of current techniques and recent developments // Pathology. 2012. №44 (7). Pp. 587–595.
  21. 21. Rubtsov N. Hybridization of nucleic acids in situ in the analysis of chromosomal abnormalities. In: Moleculargenetic methods in diagnostics of hereditary diseases and cancer. Introduction to molecular diagnostics // Moscow: Meditsina. – 2011. Vol. 2. Pp. 100–136.
  22. 22. Savage J., Simpson P. On the scoring of FISH- «painting» chromosome-type exchange aberrations // Mutat Res. 1994. №307 (1). Pp. 345–353.
  23. 23. Shakoori AR. Fluorescence In Situ Hybridization (FISH) and Its Applications // Chromosome Structure and Aberrations. 2017. №10. Pp. 343–367.
  24. 24. Song J., Mooi WJ., Petronic-Rosic V. [et al.]. Nevus versus melanoma: to FISH, or not to FISH // Adv Anat Pathol. 2011. №18. Pp. 229–234.
  25. 25. Stanley J., Hui H., Erber W. [et al.]. Analysis of human chromosomes by imaging flow cytometry. Cytometry Part B // Clinical Cytometry. 2021. №100 (5). Pp. 541–553.
  26. 26. Tanke H.J., Wiegant J., van Gijlswijk R. [et al.]. New strategy for multi-colour fluorescence in situ hybridisation: COBRA: combined binary ratio labelling // Eur. J. Hum. Genet. 1999. №7. Pp. 2–11.
  27. 27. Tubbs R., Pettay J., Roche P. [et al.]. Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression // J. Mol. Diagn. 2000. №2. Pp. 78–83.
  28. 28. Tucker J., Morgan W., Awa A. [et al.]. A proposed system for scoring structural aberrations detected by chromosome painting // Cytogenet Cell Genet. 1995. №68 (3–4). Pp. 211–221.
  29. 29. Volpi E.V., Bridger J.M. FISH glossary: an overview of the fluorescence in situ hybridization technique. 2018.
  30. 30. Volpi E.V., Bridger J.M. FISH glossary: an overview of the fluorescence in situ hybridization technique // BioTechniques. 2008. №45. Pp. 385–409. DOI 10.2144/000112811. EDN MMGAIL
  31. 31. Wertheim G., Hexner E., Bagg A. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations // Mol Diagn Ther. 2012. №16 (6). Pp. 357–369.
  32. 32. Wolff D., Bagg A., Cooley L. [et al.]. Guidance for Fluorescence in situ Hybridization Testing in Hematologic Disorders // SPECIAL ARTICLE. 2007. Vol. 9. №2. Pp. 134–143.

Comments(0)

When adding a comment stipulate:
  • the relevance of the published material;
  • general estimation (originality and relevance of the topic, completeness, depth, comprehensiveness of topic disclosure, consistency, coherence, evidence, structural ordering, nature and the accuracy of the examples, illustrative material, the credibility of the conclusions;
  • disadvantages, shortcomings;
  • questions and wishes to author.